• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

PhishPharm - Detail

  • Print
  • Share
  • E-mail
-
 
Title:  Tissue distribution and residue depletion of oxolinic acid in gilthead seabream (Sparus aurata) and sharpsnout sea bream (Diplodus puntazzo) following multiple in-feed dosings.
 
Authors:  Rigos G, Nengas I, Alexis M, Tyrpenou AE, Troisi GM
 
Drug:  Oxolinic acid
 
Fish species:  Seabream, gilthead
 
Date:  2004
 
t1/2-hr:  14
 
Sample:  skin
 
Ave Weight (gm):  170
 
Ave Water temp (°C):  19
 
Water:  Saltwater
 
Dosage:  30 mg/kg 10 d
 
Route:  PO
 
Comments:  Displayed biphasic elimination in tissues and reached "consumer safe levels 24 h after treatment. Residues ng/mg = d1=1690, d3=1330, d4=2350, d5=1710, d6=1930, d7=2180, d8=810, d9=470, d10=130, d11=40, d12=30, d14=20, d15=20, d17=20. AUC=344 ug/h ml.
 
Citation:  Aquaculture 224:245-256
 
Link:  http://dx.doi.org/10.1016/S0044-8486(03)00213-8   Opens a new window
 
Genus Species:  Sparus aurata
 
Drug Class:  Antibiotic-Quinolone
 
t1/2-detail:  14 h
 
Wt gm-detail:  170+/-25 g
 
Water temp (°C)-detail:  19 +/-1 C
 
Dosage-detail:  30 mg/kg for 10 d
 
Method:  HPLC
 
Authors-red:  Rigos G, Nengas I, Alexis M, Tyrpenou AE, Troisi GM
 
-
-